{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:11:27Z","timestamp":1785859887492,"version":"3.56.0"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"18","license":[{"start":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:00:00Z","timestamp":1746144000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5,2]]},"abstract":"<jats:p>Uterine corpus endometrioid carcinoma (UCEC) is a prevalent malignant tumor of the female reproductive system. Despite advancements in molecular biology and treatment strategies, the underlying molecular mechanisms of UCEC tumorigenesis remain incompletely understood. This study aimed to identify differentially expressed genes (DEGs) associated with UCEC pathogenesis, and to determine potential prognostic biomarkers and immunotherapy targets for UCEC. RNA expression datasets and clinical data from UCEC patients were collected from the UCSC Xena database and The Cancer Genome Atlas database. Principal component analysis and LIMMA methods were employed to screen 177 UCEC tissues and 24 normal endometrial tissues. Gene ontology enrichment analysis revealed that up-regulated DEGs were primarily involved in tissue development, cell cycle regulation, and epithelial development. Subsequently, weighted gene co-expression network analysis (WGCNA) identified DEGs in the blue modules that were significantly positively correlated with UCEC, while DEGs in the black modules were significantly negatively correlated with UCEC. Among the identified DEGs through WGCNA, 16 genes were selected, and further Kaplan\u2013Meier analysis demonstrated that 5 of these genes (AURKA, CCNE1, IQGAP3, TTK, and UBE2C) were significantly negatively correlated with overall survival (OS) and considered as hub genes. The expression of these hub genes was validated using GEO datasets and immunohistochemistry (IHC) analysis from the human protein atlas. Additionally, the calculation of immune scores for immune infiltration, immune cell infiltration, and immune cell regulation across the 5 hub genes revealed potential immunotherapeutic targets and strategies. This comprehensive investigation provides insights into the molecular mechanisms underlying UCEC development, identifies 5 promising prognostic biomarkers and immunotherapy targets, and offers guidance for UCEC treatment approaches.<\/jats:p>","DOI":"10.1097\/md.0000000000042338","type":"journal-article","created":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T22:49:18Z","timestamp":1746485358000},"page":"e42338","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Identification and validation of hub genes in uterine corpus endometrioid carcinoma: An observational study from TCGA and GEO"],"prefix":"10.1097","volume":"104","author":[{"given":"Guoxian","family":"Luo","sequence":"first","affiliation":[{"name":"Department of Gynecology, The Fourth Affiliated Hospital of Guangzhou Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caiying","family":"Bo","sequence":"additional","affiliation":[{"name":"Department of Gynecology, The Fourth Affiliated Hospital of Guangzhou Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1966-9491","authenticated-orcid":false,"given":"Jianqi","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology, Guangdong-Hong Kong-Macao Greater Bay Area Higher Education Joint Laboratory of Maternal-Fetal Medicine, The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250513","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3322\/caac.21338","article-title":"Cancer statistics in China, 2015.","volume":"66","author":"Chen","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"R2-20250513","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21654","article-title":"Cancer statistics, 2021.","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R3-20250513","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/01.NAJ.0000577332.56265.51","article-title":"CE: obesity-related cancer in women: a clinical review.","volume":"119","author":"Katz","year":"2019","journal-title":"Am J Nurs"},{"key":"R4-20250513","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0090-8258(83)90111-7","article-title":"Two pathogenetic types of endometrial carcinoma.","volume":"15","author":"Bokhman","year":"1983","journal-title":"Gynecol Oncol"},{"key":"R5-20250513","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1080\/13697137.2020.1739642","article-title":"Clinical management of vaginal bleeding in postmenopausal women.","volume":"23","author":"Carugno","year":"2020","journal-title":"Climacteric"},{"key":"R6-20250513","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ygyno.2020.04.684","article-title":"Survival of microsatellite-stable endometrioid endometrial cancer patients after minimally invasive surgery: an analysis of the Cancer Genome Atlas data.","volume":"158","author":"Dai","year":"2020","journal-title":"Gynecol Oncol"},{"key":"R7-20250513","first-page":"309","article-title":"Novel targeted therapies in ovarian and uterine carcinosarcomas.","volume":"25","author":"Han","year":"2018","journal-title":"Discov Med"},{"key":"R8-20250513","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s00404-020-05542-1","article-title":"Impact of endometrial carcinoma histotype on the prognostic value of the TCGA molecular subgroups.","volume":"301","author":"Travaglino","year":"2020","journal-title":"Arch Gynecol Obstet"},{"key":"R9-20250513","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1186\/1471-2105-9-559","article-title":"WGCNA:an R package for weighted correlation network analysis.","volume":"9","author":"Langfelder","year":"2008","journal-title":"BMC Bioinf"},{"key":"R10-20250513","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies.","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"R11-20250513","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1038\/s41598-022-08950-2","article-title":"Identification of co-expression hub genes for ferroptosis in kidney renal clear cell carcinoma based on weighted gene co-expression network analysis and The Cancer Genome Atlas clinical data.","volume":"12","author":"Li","year":"2022","journal-title":"Sci Rep"},{"key":"R12-20250513","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3389\/fonc.2018.00374","article-title":"Prognostic genes of breast cancer identified by gene co-expression network analysis.","volume":"8","author":"Tang","year":"2018","journal-title":"Front Oncol"},{"key":"R13-20250513","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma.","volume":"497","author":"Kandoth","year":"2013","journal-title":"Nature"},{"key":"R14-20250513","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data.","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat Commun"},{"key":"R15-20250513","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","article-title":"The immune landscape of cancer.","volume":"48","author":"Thorsson","year":"2018","journal-title":"Immunity"},{"key":"R16-20250513","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.7150\/thno.53649","article-title":"Siglec15 shapes a non-inflamed tumor microenvironment and predicts the molecular subtype in bladder cancer.","volume":"11","author":"Hu","year":"2021","journal-title":"Theranostics"},{"key":"R17-20250513","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles.","volume":"12","author":"Newman","year":"2015","journal-title":"Nat Methods"},{"key":"R18-20250513","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12943-020-01305-3","article-title":"Targeting AURKA in Cancer: molecular mechanisms and opportunities for Cancer therapy.","volume":"20","author":"Du","year":"2021","journal-title":"Mol Cancer"},{"key":"R19-20250513","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41419-021-03595-x","article-title":"The long-noncoding RNA SOCS2-AS1 suppresses endometrial cancer progression by regulating aurka degradation.","volume":"12","author":"Jian","year":"2021","journal-title":"Cell Death Dis"},{"key":"R20-20250513","doi-asserted-by":"crossref","first-page":"766947","DOI":"10.3389\/fonc.2021.766947","article-title":"Identification of hub genes correlated with poor prognosis for patients with uterine corpus endometrial carcinoma by integrated bioinformatics analysis and experimental validation.","volume":"11","author":"Yuan","year":"2021","journal-title":"Front Oncol"},{"key":"R21-20250513","doi-asserted-by":"crossref","first-page":"730732","DOI":"10.3389\/fgene.2021.730732","article-title":"A novel nine-gene signature associated with immune infiltration for predicting prognosis in hepatocellular carcinoma.","volume":"12","author":"Liu","year":"2021","journal-title":"Front Genet"},{"key":"R22-20250513","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1001\/jamaoncol.2022.7949","article-title":"Evaluation of Alisertib alone or combined with fulvestrant in patients with endocrine-resistant advanced breast cancer: the phase 2 TBCRC041 Randomized Clinical Trial.","volume":"9","author":"Haddad","year":"2023","journal-title":"JAMA Oncol"},{"key":"R23-20250513","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nrd4553","article-title":"Exploiting replicative stress to treat cancer.","volume":"14","author":"Dobbelstein","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"R24-20250513","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1038\/sj.onc.1207528","article-title":"Cell death by mitotic catastrophe: a molecular definition.","volume":"23","author":"Castedo","year":"2004","journal-title":"Oncogene"},{"key":"R25-20250513","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.molcel.2015.10.040","article-title":"Targeting the DNA damage response in cancer.","volume":"60","author":"O\u2019Connor","year":"2015","journal-title":"Mol Cell"},{"key":"R26-20250513","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nature14410","article-title":"Whole-genome characterization of chemoresistant ovarian cancer.","volume":"521","author":"Patch","year":"2015","journal-title":"Nature"},{"key":"R27-20250513","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1002\/cncr.21767","article-title":"Cyclin E expression is correlated with tumor progression and predicts a poor prognosis in patients with ovarian carcinoma.","volume":"106","author":"Rosen","year":"2006","journal-title":"Cancer"},{"key":"R28-20250513","doi-asserted-by":"crossref","first-page":"100394","DOI":"10.1016\/j.xcrm.2021.100394","article-title":"CCNE1 copy number is a biomarker for response to combination WEE1-ATR inhibition in ovarian and endometrial cancer models.","volume":"2","author":"Xu","year":"2021","journal-title":"Cell Rep Med"},{"key":"R29-20250513","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1200\/JCO.18.00925","article-title":"Cyclin E1 expression and palbociclib efficacy in previously treated hormone receptor-positive metastatic breast cancer.","volume":"37","author":"Turner","year":"2019","journal-title":"J Clin Oncol"},{"key":"R30-20250513","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.3892\/ol.2020.11664","article-title":"IQGAP3 promotes cancer proliferation and metastasis in high-grade serous ovarian cancer.","volume":"20","author":"Dongol","year":"2020","journal-title":"Oncol Lett"},{"key":"R31-20250513","doi-asserted-by":"crossref","first-page":"763248","DOI":"10.3389\/fmolb.2022.763248","article-title":"Comprehensive analyses of the immunological and prognostic roles of an IQGAP3AR\/let-7c-5p\/IQGAP3 axis in different types of human cancer.","volume":"9","author":"Yuan","year":"2022","journal-title":"Front Mol Biosci"},{"key":"R32-20250513","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.7150\/thno.22901","article-title":"A novel USP9X substrate TTK contributes to tumorigenesis in non-small-cell lung cancer.","volume":"8","author":"Chen","year":"2018","journal-title":"Theranostics"},{"key":"R33-20250513","doi-asserted-by":"crossref","first-page":"E1570","DOI":"10.1073\/pnas.1719577115","article-title":"Disruption of the anaphase-promoting complex confers resistance to TTK inhibitors in triple-negative breast cancer.","volume":"115","author":"Thu","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"R34-20250513","doi-asserted-by":"crossref","first-page":"e63712","DOI":"10.1371\/journal.pone.0063712","article-title":"TTK\/hMPS1 is an attractive therapeutic target for triple-negative breast cancer.","volume":"8","author":"Maire","year":"2013","journal-title":"PLoS One"},{"key":"R35-20250513","doi-asserted-by":"crossref","first-page":"34309","DOI":"10.18632\/oncotarget.5295","article-title":"TTK activates Akt and promotes proliferation and migration of hepatocellular carcinoma cells.","volume":"6","author":"Liu","year":"2015","journal-title":"Oncotarget"},{"key":"R36-20250513","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3389\/fonc.2019.00310","article-title":"Overexpression of ASPM, CDC20, and TTK confer a poorer prognosis in breast cancer identified by gene co-expression network analysis.","volume":"9","author":"Tang","year":"2019","journal-title":"Front Oncol"},{"key":"R37-20250513","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41420-022-00935-4","article-title":"Ubiquitin conjugating enzyme E2 C (UBE2C) may play a dual role involved in the progression of thyroid carcinoma.","volume":"8","author":"Xiang","year":"2022","journal-title":"Cell Death Discov"},{"key":"R38-20250513","doi-asserted-by":"crossref","first-page":"893358","DOI":"10.3389\/fgene.2022.893358","article-title":"Pan-cancer bioinformatics analysis of gene UBE2C.","volume":"13","author":"Yuan","year":"2022","journal-title":"Front Genet"},{"key":"R39-20250513","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.3389\/fonc.2019.01574","article-title":"UBE2C overexpression aggravates patient outcome by promoting estrogen-dependent\/independent cell proliferation in early hormone receptor-positive and HER2-negative breast cancer.","volume":"9","author":"Kim","year":"2020","journal-title":"Front Oncol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000042338","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T22:06:09Z","timestamp":1747173969000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000042338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,2]]},"references-count":39,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000042338","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,2]]}}}